Operating Lease, Right-of-Use Asset of BeOne Medicines Ltd. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BeOne Medicines Ltd. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • BeOne Medicines Ltd. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $148,184,000, a 6.4% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

BeOne Medicines Ltd. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $148,184,000 +$8,875,000 +6.4% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $140,217,000 +$39,171,000 +39% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $145,769,000 +$42,136,000 +41% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $146,416,000 +$58,669,000 +67% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $139,309,000 +$44,102,000 +46% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $101,046,000 +$2,304,000 +2.3% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $103,633,000 +$4,211,000 +4.2% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $87,747,000 -$21,242,000 -19% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $95,207,000 -$14,753,000 -13% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $98,742,000 -$11,598,000 -11% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $99,422,000 -$18,161,000 -15% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $108,989,000 -$6,508,000 -5.6% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $109,960,000 -$7,471,000 -6.4% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $110,340,000 +$9,755,000 +9.7% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $117,583,000 +$21,603,000 +23% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $115,497,000 +$28,551,000 +33% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $117,431,000 +$26,850,000 +30% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 $100,585,000 +$11,896,000 +13% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $95,980,000 +$5,360,000 +5.9% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $86,946,000 -$4,563,000 -5% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $90,581,000 +$8,061,000 +9.8% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $88,689,000 +$13,350,000 +18% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $90,620,000 +$15,980,000 +21% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $91,509,000 +$18,885,000 +26% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $82,520,000 +$37,462,000 +83% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $75,339,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $74,640,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $72,624,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $45,058,000 +$32,593,000 +261% 31 Dec 2018 10-K 28 Feb 2019 2018 FY
Q4 2017 $12,465,000 31 Dec 2017 10-K 28 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.